PTC THERAPEUTICS, INC. Business Finance Contracts & Agreements
47 Contracts & Agreements
- Credit Agreements (7 contracts)
- Exchange Agreements (3)
- Funding Agreements (2)
- Indenture Agreements (2)
- Investor Rights Agreements (2)
- Note Agreements (1)
- Pledge Agreements (1)
- Purchase Agreements (4)
- Security Agreements (2)
- Stock Agreements (9)
- Underwriting Agreements (6)
- Warrant Agreements (8)
- Amended and Restated Royalty Purchase Agreement, dated as of October 18, 2023, among the Registrant, Royalty Pharma Investments 2019 ICAV, and solely for the purposes of Section... (Filed With SEC on February 29, 2024)
- Funding Agreement, dated as of May 26, 2010, by and between the Registrant and The Wellcome Trust Limited (Filed With SEC on April 27, 2023)
- Amendments to the Funding Agreement, dated as of May 26, 2010, by and between the Registrant and The Wellcome Trust Limited (Filed With SEC on February 21, 2023)
- Irrevocable Transferable Standby Letter of Credit, dated June 22, 2022, issued by HSBC Bank USA, N.A. in favor of Warren CC Acquisitions LLC c/o Vision Real Estate Partners for... (Filed With SEC on August 4, 2022)
- PTC Therapeutics, Inc. Amended and Restated 2016 Employee Stock Purchase Plan (Filed With SEC on June 9, 2021)
- Royalty Purchase Agreement, dated as of July 17, 2020, by and among PTC Therapeutics, Inc., RPI 2019 Intermediate Finance Trust, and, solely for the limited purposes set forth... (Filed With SEC on August 5, 2020)
- Rights Exchange Agreement, by and among PTC Therapeutics, Inc., the Rightholders set forth therein, and, for the limited purposes set forth therein, Shareholder Representative... (Filed With SEC on April 30, 2020)
- Asset Purchase Agreement by and between PTC Therapeutics, Inc. and BioElectron, dated October 1, 2019 (Filed With SEC on October 30, 2019)
- Irrevocable Standby Letter of Credit, dated September 3, 2019, issued by HSBC Bank USA, N.A. in favor of Bristol-Myers Squibb Company for the Account of PTC Therapeutics, Inc., as... (Filed With SEC on October 30, 2019)
- Omnibus Amendment No. 5 and Joinder to Credit and Security Agreement and Amendment and Joinder to Pledge Agreement, dated as of October 1, 2019, by and among PTC Therapeutics,... (Filed With SEC on October 30, 2019)
- Amendment No. 4 to Credit and Security Agreement, dated as of September 17, 2019, by and among PTC Therapeutics, Inc., MidCap Financial Trust and the Lenders as defined therein (Filed With SEC on October 30, 2019)
- Amendment No. 3 to Credit and Security Agreement, dated as of August 29, 2019, by and among PTC Therapeutics, Inc., MidCap Financial Trust and the Lenders as defined therein (Filed With SEC on October 30, 2019)
- Amendment No. 2 to Credit and Security Agreement, dated as of August 7, 2019, by and among PTC Therapeutics, Inc., MidCap Financial Trust and the Lenders as defined therein (Filed With SEC on October 30, 2019)
- Indenture (including Form of Note), dated as of September 20, 2019, by and between PTC Therapeutics, Inc. and U.S. Bank National Association, a national banking association, as... (Filed With SEC on September 20, 2019)
- Underwriting Agreement, dated as of September 18, 2019, by and between PTC Therapeutics Inc. and Credit Suisse Securities (USA) LLC, as the Underwriter (Filed With SEC on September 20, 2019)
- Underwriting Agreement, dated January 22, 2019, by and between PTC Therapeutics, Inc. and RBC Capital Markets, LLC, as the Underwriter (Filed With SEC on January 25, 2019)
- Underwriting Agreement, dated March 28, 2018, by and among PTC Therapeutics, Inc. and Credit Suisse Securities (USA) LLC and Citigroup Global Markets Inc., as representatives of... (Filed With SEC on April 3, 2018)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. COMMERCIAL MANUFACTURING AGREEMENT (Filed With SEC on August 9, 2017)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. EXCLUSIVE LICENSE AND SUPPLY AGREEMENT (Filed With SEC on August 9, 2017)
- INTELLECTUAL PROPERTY SECURITY AGREEMENT (Filed With SEC on May 8, 2017)
- PLEDGE AGREEMENT (Filed With SEC on May 8, 2017)
- CREDIT AND SECURITY AGREEMENT dated as of May 5, 2017 by and among PTC THERAPEUTICS, INC., and any additional borrower that hereafter becomes party hereto, each as Borrower, and... (Filed With SEC on May 8, 2017)
- ASSET PURCHASE AGREEMENT by and between PTC Therapeutics, Inc., as Buyer and Marathon Pharmaceuticals, LLC, as Seller Dated as of March 15, 2017 TABLE OF CONTENTS (Filed With SEC on March 16, 2017)
- PTC THERAPEUTICS, INC. RESTRICTED STOCK AWARD AGREEMENT (Filed With SEC on March 16, 2017)
- PTC THERAPEUTICS, INC. RESTRICTED STOCK UNIT AGREEMENT (Filed With SEC on February 29, 2016)
- PTC THERAPEUTICS, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of August 14, 2015 3.00% Convertible Senior Notes due 2022 (Filed With SEC on August 14, 2015)
- PTC Therapeutics, Inc. Inducement Grant Nonstatutory Stock Option Agreement (Filed With SEC on March 2, 2015)
- PTC THERAPEUTICS, INC. 3,000,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on October 10, 2014)
- PTC THERAPEUTICS, INC. Shares of Common Stock Underwriting Agreement (Filed With SEC on February 10, 2014)
- PTC THERAPEUTICS, INC. Shares of Common Stock Underwriting Agreement (Filed With SEC on June 5, 2013)
- PTC Therapeutics, Inc. NOTICE OF AWARD FOR NONSTATUTORY STOCK OPTION (Filed With SEC on May 28, 2013)
- PTC Therapeutics, Inc. NOTICE OF AWARD FOR NONSTATUTORY STOCK OPTION (Filed With SEC on May 16, 2013)
- PTC Therapeutics, Inc. NON-QUALIFIED STOCK OPTION CERTIFICATE (Filed With SEC on May 16, 2013)
- PTC THERAPEUTICS, INC. EIGHTH AMENDED AND RESTATED 1998 EMPLOYEE, DIRECTOR AND CONSULTANT STOCK OPTION PLAN (Filed With SEC on May 16, 2013)
- PTC THERAPEUTICS, INC. SECOND AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT Dated as of March 7, 2013 (Filed With SEC on May 16, 2013)
- EX-10.14: FORM OF PROMISSORY NOTE (Filed With SEC on March 31, 2006)
- EX-10.13: MASTER SECURITY AGREEMENT (Filed With SEC on March 31, 2006)
- EX-10.1: SIXTH AMENDED AND RESTATED 1998 STOCK OPTION PLAN (Filed With SEC on March 31, 2006)
- EX-4.10: WARRANT (Filed With SEC on March 31, 2006)
- EX-4.9: WARRANT (Filed With SEC on March 31, 2006)
